Points to Consider: Challenges for Alternative BET Assays
Posted on October 20, 2021
Karen Zink McCullough, Principal Consultant, MMI Associates
Introduction Innovation in any aspect of pharmaceutical science requires a set of clear, accurate and shared expectations, assumptions, definitions and goals to assure that advancements can be readily and broadly accepted by all stakeholders. Due to the criticality of pyrogen and endotoxin testing, ...
To read the full article and other articles in this issue, please register for a free account or log in.
We will not sell or give your information to a third party. See our Privacy Policy
Subscribe to our FREE newsletter and WEBINAR UPDATES
We will not sell or give your information to a third party. See our Privacy Policy















